Doubts raised over cancer vaccine studyBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7306.184/c (Published 28 July 2001) Cite this as: BMJ 2001;323:184
- Annette Tuffs
A prizewinning German study claiming to have found a safe and effective vaccine for kidney cancer has been heavily criticised by doctors who say that the research data may have been manipulated and that the treatment could even be dangerous.
Alexander Kugler, a senior registrar in the urology department of Göttingen University Hospital, and Gernot Stuhler, an oncologist from Tübingen University, treated 17 patients with metastasising kidney cancer with a vaccine made from a hybrid of cancer and immune cells. Their study, published in March last year, reported that after …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial